AptarGroup Forecasts Q4 Adjusted EPS of $1.39 to $1.47 Per Share

The company expects the emergency-medicine destocking impact to be behind it in Q4. Management expects Pharma to drive a strong year-end finish and forecasts year-over-year margin improvement.

Leave a Reply

Your email address will not be published. Required fields are marked *

UP NEXT

Related Tags

Loading RSS Feed

You May Like

Subscribe To Our Newsletter

Metus in ac vivamus dui id purus in risus. Nunc fringilla donec amet pulvinar vivamus suscipit. Augue porttitor eu sed proin tortor bibendum facilisis felis. Nunc egestas tellus nisl tempor aliquet malesuada ali eu sed proin tortor bibendum facilisis felis
Stay Updated by our Monthly / Weekly News Update. Zero Spamming. Terms & Condition Applied